Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients

Infection

Volumn 26, Issue 2, 1998, Pages 100-103

  Hittinger, G ^a   Poggi, C ^a   Delbeke, E ^a   Profizi, N ^a   Lafeuillade, A ^a  

^a Hopital Chalucet Toulon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VIRUS RNA;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE;

EID: 0031938303     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02767768     Document Type: Article

References (24)

1. Poli, G., Fauci, A. S.: Cytokine cascades in HIV infection. In: Gupta. S. (ed.), Immunology of HIV infection. Plenum Press, New York 1996, pp. 285-301.
2. Wyakamam, A., McKeating, J., Meager, A., Beverley, P. C.: Tumour necrosis factors (α,β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 4 (1990) 21-27.
3. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., Lusso, P.: Identification of RANTES. MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270 (1995) 1811-1815.
4. Cohen, J.: Chemokines share center stage with drug therapies. Science 273 (1996) 302-303.
5. Thea, D. M., Porat, R., Nagimbi, K., Baangi, M., St. Louis, M. E., Kaplan, G., Dinarello, C. A., Keusch, G. T.: Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann. Intern. Med. 124 (1996) 757-762.
6. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Detsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn B. H., Saag, M. S., Shaw, G. M.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373 (1995) 117-122.
7. Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., Gupta, P.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122 (1995) 573-579.
8. Zanussi, S., D'Andrea, M., Simonelli, C., Tirelli, U., De Paoli, P.: Serum levels of RANTES and MIP-1α in HIV-positive long-term survivors and progressor patients. AIDS 10 (1996) 1431-1432.
9. Salazar-Gonzalez, J. F., Martinez-Maza, O., Aziz, N., Kolberg, J. A., Yeghiazarian, T., Shen, L.-P., Fahey, J. L.: Relationship of plasma HIV-RNA levels and levels of TNF-α and immune activation products in HIV infection. Clin. Immunol. Immunopathol. 84 (1997) 36-45.
10. Barcellini, W., Rizzardi, G. P., Poli, G., Tambussi, G., Velati, C., Meroni, P. L., Lazzarin, A.: Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection. AIDS Res. Hum. Retroviruses 12 (1996) 325-331.
11. Gotfried, M. H., van der Pol, T., Weverling, G. J., Mulder, J. W., Jansen, J., Van Deventer, S. J., Sauerwein, H. P.: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 169 (1994) 739-745.
12. Bilello, J. A., Stellrecht, K., Drusano, G. L., Stein, D. S.: Soluble tumor necrosis factor-α receptor type II (sTNF-α RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J. Infect. Dis. 173 (1996) 464-467.
13. Cremoni, L., Vaira, L. L., D'Amico, P., Grassi, M. G., Milazo, F.: Does zidovudine reduce tumour necrosis factor-α in HIV-positive patients? AIDS 7 (1993) 128-129.
14. Li, Q., Gebhard, K., Schacker, T., Henry, K., Haase, A. T.: The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue. J. Virol. 71 (1997) 7080-7082.
15. Klausner, J. D., Makonkawkeyoon, S., Akarasewi, P., Nakata, K., Kasinrerk, W., Corral, L., Dewar, R. L., Lane, H. C., Freedman, V. H., Kaplan, G.: The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection. J. Acquir. Immune Defic. Syndr. 11 (1996) 247-257.
16. Walker, R. E., Spooner, K. M., Kelly, G., McCloskey, R. V., Woody, J. N., Falloon, J., Baseler, M., Piscitelli, S. C., Davey, R. T. Jr., Polis, M. A., Kovacs, J. A., Masur, H., Lane, H. C.: Inhibition of immunoreactive tumor necrosis factor-α by a chimeric antibody in patients infected with human immunodeficiency virus type 1. Infect. Dis. 174 (1996) 63-68.
17. Navikas, V., Link, J., Persson, C., Olsson, T., Hojeberg, B., Ljungdahl, A., Link, H., Wahren, B.: Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9 (1995) 484-489.
18. Bisset, L. R., Rothen, M., Joller-Jemelka, H. I., Dubs, R. W., Grob, P. J., Opravil, M.: Changes in circulating levels of the chemokines macrophage inflammatory proteins 1 α and 1 β, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 11 (1997) 485-491.
19. Cook, D. N.: The role of MIP-1 alpha in inflammation and hematopoiesis. J. Leukoc. Biol. 59 (1996) 61-66.
20. Zhou, Z., Kim, Y. T., Pollok, K., Hurtado, J., Lee, J. K., Broxmever, H. E., Kwon, B. S.: Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes. J. Immunol. 151 (1993) 4333-4341.
21. Klinger, M. H., Wilhelm, D., Buhel, S., Sticherling, M., Schroder, J. M., Kuhnel, W.: Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int. Arch. Allergy Immunol. 104 (1995) 541-546.
22. Blazevic, V., Heino, M., Jussila, T., Krohn, K. J. E.: RANTES. MIP and interleukin-16 in HIV infection. AIDS 10 (1996) 1435-1436.
23. Smith, M. W., Dean, M. Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M. W., Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort, O'Brien, S. J.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277 (1997) 959-965.
24. Pantaleo, G.: How immune-based interventions can change HIV therapy. Nature Med. 3 (1997) 483-486.